A Phase 1, Single-Center, Split-Face Study Assessing Local Cutaneous Effects After Application of SB204 2% and SB204 4% in Healthy Volunteers
Latest Information Update: 27 Nov 2018
At a glance
- Drugs Berdazimer sodium (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Novan Inc
Most Recent Events
- 29 Sep 2014 New trial record